Hana Biosciences Inc., of South San Francisco, elected David Allen Galbraith to its board.

Heska Corp., of Fort Collins, Colo., appointed Elisabeth DeMarse to its board.

Hollis-Eden Pharmaceuticals Inc., of San Diego, appointed Steven Gordziel vice president of product development.

Hybridon Inc., of Cambridge, Mass., appointed Alison Taunton-Rigby to its board, and Naveen Anand vice president of corporate and business development.

Icogenex Corp., of Seattle, appointed George Martin scientific adviser for the Alzheimer's disease program.

Insmed Inc., of Richmond, Va., appointed Kenneth Attie medical director.

Interleukin Genetics Inc., of Waltham, Mass., elected William Viveen to its board.

Isolagen Inc., of Houston, appointed Dennis Bevan vice president of international commercial operations.

Keryx Biopharmaceuticals Inc., of New York, appointed Eric Rose to its board.

Ligand Pharmaceuticals Inc., of San Diego, engaged BDO Seidman LLP as its independent registered public accounting firm.

Matritech Inc., of Newton, Mass., appointed Gary Fagan vice president of research and development.

Maxim Pharmaceuticals Inc., of San Diego, appointed John Bedard to its board.

MDS Pharma Services, of Montreal, appointed Beverly Harrison vice president for clinical operations in North America.

Memory Pharmaceuticals Corp., of Montvale, N.J., appointed Peter Young to its board.

Merial Ltd., of Duluth, Ga., appointed Gerald Belle executive chairman.

Microbia Inc., of Cambridge, Mass., appointed David Shaw to its board.

Miikana Therapeutics Inc., of Fremont Calif., appointed Anthony Neri vice president of preclinical discovery.

Millennium Pharmaceuticals Inc., of Cambridge, Mass., appointed Laurie Keating senior vice president, general counsel and secretary.

Neose Technologies Inc., of Horsham, Pa., expects to name Brain Davis chief financial officer in January, upon the retirement of Robert Kriebel.

Neurion Pharmaceuticals Inc., of Pasadena, Calif., appointed Paul Bennett vice president of discovery.

Neurochem Inc., of Montreal, appointed Andreas Orfanos executive vice president of strategic planning and scientific affairs.

Norwood Abbey Ltd., of Melbourne, Australia, appointed Elizabeth Wyatt, Richard Zahn and Ian Hunter to its board.